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chip (including 38,500 genes and 4,700 gene transcripts).
RESULTS Microarray results showed that after 48 hours, 4343 gene
transcripts differed (p<0.05) between controp group and HCY group.
Fuctional analysis showed a signiﬁcant number of genes to be
associated with apoptosis, cell cycle pathway, enzyme, immunity
protein, microtubular dynamic, nucleic acid binding,signal trans-
ducer. 3409 gene transcripts were up-regulated while 121 gene
transcripts were down-regulated in HUVEC treated with TXL. These
gene transcripts have been proved to relate to biological process,
molecular function and cellular structure. Signiﬁcant changes were
observed in genes involved in apoptosis, cellular proliferation, cell
signal transduction and oxidative stress. including vescular endo-
thelial growth factor (VEGF), IGF receptors, p42/44 mitogen acti-
vated protein (MAP) kinase, endothelial nitric oxide synthase (eNOS),
chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-C motif) ligand
5 (CCL5), chemokine (C-X-C motif) ligand 10 (CXCL10), and toll like
receptor 3 (TLR3).
CONCLUSIONS TXL may protect endothelial function via the regula-
tion of gene expression which involved in apoptosis, cellular prolif-
eration, cell signal transduction and oxidative stress.GW26-e4023
Prenatal Lipopolysaccharide Exposure Causes Mesenteric Vascular
Dysfunction Through the NO-cGMP Pathway in Offspring
W.A.N.G. Xinquan, Z.E.N.G. Chunyu
Department of Cardiology, Daping Hospital, The Third Military Medical
University, Chongqing, China
OBJECTIVES Cardiovascular diseases, such as hypertension, could be
programmed in fetal life. Prenatal lipopolysaccharide (LPS) exposure
in utero results in increased blood pressure in offspring, but the
vascular mechanisms involved are unclear.
METHODS Pregnant Sprague–Dawley (SD) rats were intraperitoneally
injected with LPS (0.79 mg/kg) or saline (0.5 ml) on gestation day 8,
10, and 12, and the vascular function was tested after treatment with
vehicle or TEMPOL in offspring at 15 weeks.
RESULTS The offspring of LPS-treated dams had higher blood pres-
sure and decreased acetylcholine (ACh)-induced relaxation and
increased phenylephrine (PE)-induced contraction in endothelium-
intact mesenteric arteries. Endothelium removal signiﬁcantly
enhanced the PE-induced contraction in offspring of control but not
LPS-treated dams. The arteries pretreated with L-NAME to inhibit
nitric oxide synthase (eNOS) in the endothelium or ODQ to inhibit
cGMP production in the vascular smooth muscle, had attenuated ACh-
induced relaxation but augmented PE-induced contraction to a larger
extent in arteries from offspring of control than those from LPS-
treated dams. In addition, the endothelium-independent relaxation
caused by sodium nitroprusside (SNP) was also decreased in arteries
from offspring of LPS-treated dams. The functional results were
accompanied by a reduction in the expressions of eNOS and soluble
guanylate cyclase (sGC) and production of NO and cGMP in arteries
from offspring of LPS-treated dams. Furthermore, LPS-treated dam’s
offspring arteries had increased oxidative stress and decreased anti-
oxidant capacity. Three-week treatment with TEMPOL, a reactive
oxygen species (ROS) scavenger, normalized the alterations in the
levels of ROS, eNOS, and sGC, as well as in the production of NO and
cGMP and vascular function in the arteries of the offspring of LPS-
treated dams.
CONCLUSIONS Prenatal LPS exposure programs vascular dysfunction
of mesenteric arteries through increased oxidative stress and
impaired NO-cGMP signaling pathway.GW26-e4401
MiR-195-3p/-5p decrease cardiac ﬁbroblast proliferation and the
transdifferentiation into myoﬁbroblasts
Shutong Shen, Xinli Li
jiangsu province hospital
OBJECTIVES MicroRNAs (miRNAs, miRs) contribute to many essen-
tial physiological and pathological processes including ﬁbrosis. This
study aims at investigating the role of miR-195-3p/-5p in cardiac
ﬁbroblast proliferation and the transdifferentiation into
myoﬁbroblasts.
METHODS Neonatal cardiac ﬁbrobasts (NRCFs) were isolated and
miR-195-3p/-5p was forced expressed with agomiRs. Proliferation asdetermined by EdU and Ki67 staining. a-SMA (a marker of myoﬁ-
broblast transdifferentiation) was determined by quantitative
reverse transcription polymerase chain reactions (RT-PCRs) and
western blotting (WB). Target genes of miR-195-3p/-5p were detected
by WB.
RESULTS In isolated primary neonatal cardiac ﬁbrobasts (NRCFs),
forced expression of miR-195-3p/-5p with agomiRs could attenuate
ﬁbrobast proliferation as determined by EdU and Ki67 staining
while inhibition of miR-195-3p/-5p with antagomiRs could increase
ﬁbrobast proliferation. By quantitative reverse transcription poly-
merase chain reactions (RT-PCRs) and western blotting (WB), a-SMA
(a marker of myoﬁbroblast transdifferentiation) was found to be
suppressed in the miR-195-3p/-5p agomiR-treated NRCFs at both
mRNA and protein levels, while was increased in the miR-195-
3p/-5p antagomiR-treated NRCFs. Moreover, Chek-1 was identiﬁed
as a target gene of miR-195-3p/-5presponsible for cardiac ﬁbroblast
proliferation and the transdifferentiation into myoﬁbroblasts by
RT-PCR and WB and immunoﬂuorescent staining. Silencing of
Chek-1 attenuates cardiac ﬁbroblast proliferation and the trans-
differentiation into myoﬁbroblasts as detected by a-SMA/EDU
staining. In addition, Chek-1 mediated the effects of miR-195-3p/-5p
in cardiac ﬁbroblast proliferation and the transdifferentiation into
myoﬁbroblasts.
CONCLUSIONS MiR-195-3p/-5p decrease cardiac ﬁbroblast prolifera-
tion and the transdifferentiation into myoﬁbroblasts. Therefore,
miR-195-3p/-5p might be promising therapeutic targets for cardiac
ﬁbrosis.
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Effect of Extract of Leaves of Ginkgo biloba pretreatment on rat
Cardiomyocytes with hypoxia / reoxygenation injury
Xiaoping Wang,1 Yanmei Zhu,2 Yushan Huang3
1Vasculocardiology department, Gannan Medical College; 2Chengdu
medical college; 3Colledge of Medicine, Jinggangshan University
OBJECTIVES To study the effect and mechanism of Extract Leaves of
Ginkgo biloba (EGb) pretreatment on rat Cardiomyocytes with hyp-
oxia/reoxygenation (H/R) injury.
METHODS Cardiomyocytes were pre-incubated with extact leaves of
Ginkgo biloba, hypoxia reoxygenation model on myocardial ischemia
reperfusion injury after 2 h, and then detected the cell viability, MDA
content, SOD activity and GSH / GSSG ratio. The effects of EGb on
Keap1, Nrf2, GCLC and GSTP1 mRNA expression were determined by
RT-PCR method.
RESULTS The cell viability, SOD activity and GSH/GSSG ratio of EGb
pretreatment group increased signiﬁcantly compared with H/R group,
whereas the MDA content reduced signiﬁcantly; Keap1 mRNA
expression reduced signiﬁcantly, while Nrf2, GCLC and GSTP1 mRNA
expression increased signiﬁcantly, and the difference among with
three concentrations were conspicuous; these changes were reversed
after ATRA added.
CONCLUSIONS EGb plays a protection role in cardiomyocytes H/R
injury, and its mechanism was associated with Keap1 / Nrf2 / ARE
signaling pathway.GW26-e4505
Type 2 Ryanodine Receptor Hyperphosphorylation Plays a Role in the
Development of Hypertensive Heart Failure
Kangyin Chen,1 Tigang Huang,1 Tong Liu,1 Yong-Jian Li,3 Xin Zhou,2
Wei Cai,2 Guangping Li,1 Yuming Li2
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OBJECTIVES Type 2 ryanodine receptor (RYR2) hyperphos-
phorylation plays an important role in the development of myocardial
infarction caused heart failure (HF). However, it remains unclear
that whether there is similar process in the development of hyper-
tensive left ventricular hypertrophy (LVH) and heart failure (HF).
We tested the hypothesis that RYR2 hyperphosphorylation
also plays an important role in the development of hypertensive LVH
and HF.
METHODS Hypertensive LVH (70% diameter stenosis, n¼16) and HF
(90% diameter stenosis, n¼12) rabbit models were prepared through
C58 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5abdominal aorta constriction, and conﬁrmed with echocardiographic
and hemodynamic measurements. The rabbits in the Sham group
(n¼14) received the same procedure without abdominal aorta
constriction. Eight weeks after the index procedure, ex vivo electro-
physiological parameters were determined. The protein expression
levels of RYR2, phosphorylated RYR2 (RYR2p), FKBP12 was deter-
mined using western-blot. The level of RYR2 phosphorylation was
deﬁned as the ratio of RYR2p to RYR2.
RESULTS Compared to the Sham group, the LVH group had a signif-
icantly shorter left ventricular effective refractory period (122.75 
10.31 ms vs 95.71  16.31 ms, P <0.001). Six isolated hearts (6/8) in the
LVH group occurred inducible ventricular tachycardia or ventricular
ﬁbrillation under program stimulation, while none (0/8) in the Sham
group occurred arrhythmia (P ¼0.007). All hearts (6/6) in the HF group
occurred spontaneous ventricular ﬁbrillation, while the other two
groups didn’t have. Compared to the Sham group, the LVH group had
signiﬁcantly higher protein expression of RYR2, RYR2p, and FKBP12
(P <0.05), while the level of RYR2 phosphorylation didn’t differ
signiﬁcantly between these two groups. Compared to the sham group,
the HF group had signiﬁcantly lower protein levels of RYR2 and
FKBP12, but higher levels of RYR2p and RYR2 phosphorylation ratio
(P <0.05).
CONCLUSIONS The present study showed that despite of the altered
expression levels of RYR2 in both LVH and HF, the ratio of RYR2
phosphorylation only increased in HF rather than in LVH, suggesting
RYR2 hyperphosphorylation may play an important role in the
development of hypertensive HF. Furthermore, the altered RYR2
expression and phosphorylation level might be translated into more
vulnerable electrophysiological characteristics.
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Loss of Osteoglycin Promotes Angiogenesis in Limb Ischemia Mouse Model
via Modulation of VEGF-VEGFR2 Signaling Pathway
Qihong WU, Yu Ma, Chengchao Ruan, Yan Yang, Qian Ge, Ke Zhang,
Hui Jiang, Mona Hong, Pingjin Gao
Shanghai Institute of Hypertension
OBJECTIVES Osteoglycin (OGN) plays important roles in cardiovas-
cular disease. However, the relationship between OGN and angio-
genesis remains unknown. Therefore, we sought to investigate the
effect of OGN on ischemia-induced angiogenesis and address the
underlying mechanisms.
METHODS Expression of OGN on endothelial cells (ECs) in angio-
genic tissue was detected. Limb ischemia model was established in
OGN knockout (KO) (n¼12) and wild type (WT) (n¼12) mice. Laser
Doppler imaging was used to estimate perfusion recovery. Mean-
while, aortic rings assay was used as ex vivo model of angiogenesis.
Small interfering RNA was used to knock down OGN expression in
culturing human umbilical vein endothelial cells (HUVECs), and cell
functions were assessed in subsequent study. Protein-protein inter-
action was revealed by co-immunoprecipitation assay. And molecu-
lar docking was performed to predict the binding site of OGN to
VEGFR2.
RESULTS OGN was down regulated in intermuscular endothelial cells
during angiogenesis in patients of peripheral artery disease and mice
model of limb ischemia. OGN knockout promoted perfusion as
femoral artery ligation. The blood ﬂow recovery of WT mice after
ischemia induction was 24.8%, 44.6% and 63.5% respectively at day4,
day7 and day14, while that of KO mice was 46.5%, 71.5%, and 83.0%
coordinately. Capillary density indicating by CD31 positive staining
was also higher in OGN KO mice in the gastrocnemicus muscle of the
ischemia limb. But no difference of inﬂammatory cells inﬁltration
between two groups was observed. Aortic rings isolated from OGN KO
mice had stronger sprouting than those from WT ones. In vitro study
revealed tube formation, proliferation, and migration of HUVECs were
enhanced in OGN knockdown group, compared with negative control
group. OGN knockdown did not alter protein level of VEGF or
VEGFR2, but changed activation of VEGFR2 and its downstream
signaling pathways as Akt an ERK1/2. Co-immunoprecipitation assay
revealed association of OGN and VEGFR2 both in vitro and in vivo.
And OGN was found to modulate interaction of VEGF and VEGFR2.
Molecular docking showed OGN docked into the binding pocket of
VEGFR2 on the extracellular domain2 and domain3, which is the exact
binding site of VEGF.
CONCLUSIONS This study demonstrates the crucial role of OGN
in the setting of ischemia-induced angiogenesis. Down regulation
of OGN promoted endothelial cell functions and angiogenic path-
ways. In mechanism, this phenomenon can be attributed to OGNbinding to VEGFR2 and modulation of VEGF-VEGFR2 signaling
pathway.
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The role of Hippo signal transduction pathway in the development of
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OBJECTIVES This research will explore the expression of Hippo
signal transduction pathway in the patients with hypertrophic car-
diomyopathy and the regulation of this pathway and its related gene
in the development of cardiac hypertrophy, and explore the possible
role of Hippo signal transduction pathway in hypertrophic
cardiomyopathy.
METHODS Myocardial tissues of 32 patients with hypertrophic car-
diomyopathy, who accept the Marrow’s surgery in Beijing Anzhen
Hospital from September 2011 to April 2013 and 4 cases of normal
myocardial tissue were harvested and then protein and RNA of these
tissues were also extracted and tested to detect the expression of
Hippo signal transduction pathways in the protein and the mRNA
level clinical specimens. Speciﬁc cardiomyocytes YAP transgenic
mice, as well as the Isoproterenol (ISO) cardiac hypertrophic model,
are used to explore the possible molecular mechanism of Hippo signal
transduction pathway in the process of promoting cardiac hypertro-
phy. Using mouse primary cultured cardiomyocytes explore the
mechanism of this pathway in vitro.
RESULTS The expression of protein and mRNA of MST in tissues of
hypertrophic cardiomyopathy is less than normal myocardial tissue,
the expression of protein and mRNA of YAP in tissues of hypertrophic
cardiomyopathy is more than normal myocardial tissue and the
expression of YAP-S127 declines. Same results are obtained in HCM
model mice.
CONCLUSIONS The abnormal expression of Hippo signal trans-
duction pathways regulates myocardial cell hyperplasia and prolifer-
ation and promotes the occurrence of hypertrophic cardiomyopathy.
Low expression of MST in Hippo pathway can upregulate the activity
of the pathway downstream gene (YAP) and the other speciﬁc genes to
regulate the proliferation of myocardial cells, which affects the
myocardial hypertrophy and participates in the development of hy-
pertrophic cardiomyopathy.
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DIM attenuates TGF-b1-induced myoﬁbroblast differentiation in neonatal
rat cardiac ﬁbroblasts through AKT/GSK-3b signaling pathways
Jin Li, Zheng Yang, Yuan Yuan, Qingqing Wu, Qizhu Tang
Department of cardiology, Renmin Hospital of Wuhan university
OBJECTIVES 3,3’-Diindolylmethane (DIM) is a natural component of
cruciferous plants. Previous studies have shown that DIM has multi-
ple physiological effects including anti - angiogenic, anti-inﬂamma-
tory and anti-cancer effect. However, little is known about the role of
DIM on myoﬁbroblast differentiation and extracellular matrix (ECM)
production. This study aimed to investigated the effect of DIM on
myoﬁbroblast differentiation and ECM production in neonatal rat
cardiac ﬁbroblasts induced by transforming growth factor b1 (TGF-b1).
METHODS The neonatal rat cardiac ﬁbroblasts in vitro were stimu-
lated with TGF-b1 (1 mmol/L) for 48 h to induce myoﬁbroblast differ-
entiation. Cell viability was examined by CCK8, the percentage of
positive cardiac ﬁbroblasts was measured with immunoﬂuorescence
staining. The mRNA expression levels of ﬁbrotic markers were
measured with Real-time PCR and the protein expression levels of
AKT and glycogen synthase kinase-3b (GSK-3b) were examined with
Western Blotting analysis.
RESULTS Our data showed that DIM could dramatically blunt the
percentage of positive cardiac ﬁbroblasts which express a-smooth
muscle actin (a-SMA) protein induced by TGF-b1, and reduced the
mRNA and protein expressions of a-SMA. Moreover, DIM also signif-
icantly decreased the mRNA expression of ﬁbrotic markers (Collagen I,
